APA (7th ed.) Citation

Åkerblom, A., Oldgren, J., Latva-Rasku, A., Johansson, L., Lisovskaja, V., Karlsson, C., . . . Nuutila, P. (2019). Effects of DAPAgliflozin on CARDiac substrate uptake, myocardial efficiency, and myocardial contractile work in type 2 diabetes patients—a description of the DAPACARD study. Upsala Journal of Medical Sciences, 124(1), 59. https://doi.org/10.1080/03009734.2018.1515281

Chicago Style (17th ed.) Citation

Åkerblom, Axel, Jonas Oldgren, Aino Latva-Rasku, Lars Johansson, Vera Lisovskaja, Cecilia Karlsson, Jan Oscarsson, and Pirjo Nuutila. "Effects of DAPAgliflozin on CARDiac Substrate Uptake, Myocardial Efficiency, and Myocardial Contractile Work in Type 2 Diabetes Patients—a Description of the DAPACARD Study." Upsala Journal of Medical Sciences 124, no. 1 (2019): 59. https://doi.org/10.1080/03009734.2018.1515281.

MLA (9th ed.) Citation

Åkerblom, Axel, et al. "Effects of DAPAgliflozin on CARDiac Substrate Uptake, Myocardial Efficiency, and Myocardial Contractile Work in Type 2 Diabetes Patients—a Description of the DAPACARD Study." Upsala Journal of Medical Sciences, vol. 124, no. 1, 2019, p. 59, https://doi.org/10.1080/03009734.2018.1515281.